Isoflurane: Patients will receive general anesthesia and maintenance by isoflurane.
Sevoflurane: Patients will receive general anesthesia and maintenance by sevoflurane.
Study summary
The primary aim of this work is to assess the impact of exposure to isoflurane or sevoflurane as an inhalation anesthetic on the oxidative stress and inflammatory conditions in patients undergoing elective moderate invasive surgery (laparoscopic cholecystectomy).
Eligibility
Sex
ALL
Min age
20 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria:
* Age from 20 to 60 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) Physical Status I-II.
* Undergoing elective laparoscopic cholecystectomy under general anesthesia.
Exclusion Criteria:
* Refusal of participation in the study by patients.
* Diabetes (type I or II), endocrine system, and immune system diseases.
* Chronic infection and sepsis.
* Cardiac condition as classified bythe New York Heart Association (NYHA) \> class II.
* Hepatic disease: INR \> 1.5, and/or albumin \< 2.5 g/dL.
* Renal disease: glomerular filtration rate (GFR) \< 85 ml/min.
* Mental and neurological disorders.
Primary outcome measure(s)
Serum level of superoxide dismutase — 6 months postoperatively Serum level of superoxide dismutase (SOD) will be recorded.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.